133 related articles for article (PubMed ID: 8577920)
1. Paclitaxel: a unique tubulin interacting anticancer agent.
Vyas DM; Kadow JF
Prog Med Chem; 1995; 32():289-337. PubMed ID: 8577920
[No Abstract] [Full Text] [Related]
2. Synthesis of a paclitaxel isomer: C-2-acetoxy-C-4-benzoate paclitaxel.
Chen SH; Farina V; Vyas DM; Doyle TW
Bioorg Med Chem Lett; 1998 Aug; 8(16):2227-30. PubMed ID: 9873518
[TBL] [Abstract][Full Text] [Related]
3. Tubulin-targeting agents.
Hait WN; Rubin E; Goodin S
Cancer Chemother Biol Response Modif; 2003; 21():41-67. PubMed ID: 15338740
[No Abstract] [Full Text] [Related]
4. Synthetic chemistry. Cancer drugs better than taxol?
Cowden CJ; Paterson I
Nature; 1997 May; 387(6630):238-9. PubMed ID: 9153384
[No Abstract] [Full Text] [Related]
5. The shape of things to come: structural and synthetic studies of taxol and related compounds.
Kingston DG
Phytochemistry; 2007 Jul; 68(14):1844-54. PubMed ID: 17184797
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of paclitaxel-mimics possessing only the oxetane D-ring and side chain structures.
Chen XX; Gao F; Wang Q; Huang X; Wang D
Fitoterapia; 2014 Jan; 92():111-5. PubMed ID: 24211350
[TBL] [Abstract][Full Text] [Related]
7. Recent progress in structure activity relationship and mechanistic studies of taxol analogues.
Fang WS; Liang XT
Mini Rev Med Chem; 2005 Jan; 5(1):1-12. PubMed ID: 15638787
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of A-nor-paclitaxel analogues.
Chordia MD; Kingston DG; Hamel E; Lin CM; Long BH; Fairchild CA; Johnston KA; Rose WC
Bioorg Med Chem; 1997 May; 5(5):941-7. PubMed ID: 9208103
[TBL] [Abstract][Full Text] [Related]
9. A molecular docking study of anticancer drug paclitaxel and its analogues.
Sinha R; Vidyarthi AS; Shankaracharya
Indian J Biochem Biophys; 2011 Apr; 48(2):101-5. PubMed ID: 21682141
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of water-soluble paclitaxel prodrugs.
Feng X; Yuan YJ; Wu JC
Bioorg Med Chem Lett; 2002 Nov; 12(22):3301-3. PubMed ID: 12392737
[TBL] [Abstract][Full Text] [Related]
11. [Development of a new tubulin-interacting agent, docetaxel (taxotere) in Japan].
Tsukagoshi S
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1167-74. PubMed ID: 9239173
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of paclitaxel (Taxol) analogs modified at positions C-2, C-7, and C-3' on tubulin polymerization and polymer stabilization: identification of a hyperactive paclitaxel derivative.
Grover S; Rimoldi JM; Molinero AA; Chaudhary AG; Kingston DG; Hamel E
Biochemistry; 1995 Mar; 34(12):3927-34. PubMed ID: 7696257
[TBL] [Abstract][Full Text] [Related]
13. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
[TBL] [Abstract][Full Text] [Related]
14. The chemistry of taxol and related taxoids.
Kingston DG; Jagtap PG; Yuan H; Samala L
Fortschr Chem Org Naturst; 2002; 84():53-225. PubMed ID: 12132389
[No Abstract] [Full Text] [Related]
15. Synthesis and biological evaluation of 2'-carbamate-linked and 2'-carbonate-linked prodrugs of paclitaxel: selective activation by the tumor-associated protease plasmin.
de Groot FM; van Berkom LW; Scheeren HW
J Med Chem; 2000 Aug; 43(16):3093-102. PubMed ID: 10956217
[TBL] [Abstract][Full Text] [Related]
16. A convenient tubulin-based quantitative assay for paclitaxel (Taxol) derivatives more effective in inducing assembly than the parent compound.
Lin CM; Jiang YQ; Chaudhary AG; Rimoldi JM; Kingston DG; Hamel E
Cancer Chemother Pharmacol; 1996; 38(2):136-40. PubMed ID: 8616903
[TBL] [Abstract][Full Text] [Related]
17. Tubulins - the target for anticancer therapy.
Vindya NG; Sharma N; Yadav M; Ethiraj KR
Curr Top Med Chem; 2015; 15(1):73-82. PubMed ID: 25579568
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the tubulin-bound paclitaxel conformation: synthesis, biology, and SAR studies of C-4 to C-3' bridged paclitaxel analogues.
Ganesh T; Yang C; Norris A; Glass T; Bane S; Ravindra R; Banerjee A; Metaferia B; Thomas SL; Giannakakou P; Alcaraz AA; Lakdawala AS; Snyder JP; Kingston DG
J Med Chem; 2007 Feb; 50(4):713-25. PubMed ID: 17263521
[TBL] [Abstract][Full Text] [Related]
19. Use of the tubulin bound paclitaxel conformation for structure-based rational drug design.
Geney R; Sun L; Pera P; Bernacki RJ; Xia S; Horwitz SB; Simmerling CL; Ojima I
Chem Biol; 2005 Mar; 12(3):339-48. PubMed ID: 15797218
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and anticancer activity of phosphonic acid diphosphate derivative of adenine-containing butenolide and its water-soluble derivatives of paclitaxel with high antitumor activity.
Moosavi-Movahedi AA; Hakimelahi S; Chamani J; Khodarahmi GA; Hassanzadeh F; Luo FT; Ly TW; Shia KS; Yen CF; Jain ML; Kulatheeswaran R; Xue C; Pasdar M; Hakimelahi GH
Bioorg Med Chem; 2003 Oct; 11(20):4303-13. PubMed ID: 13129566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
